Date	Chamber	Action
1/9/2019	Senate	Session Sine Die

Statutes Amended In Order of Appearance

215 ILCS 134/45.3 new

Synopsis As Introduced
Amends the Managed Care Reform and Patient Rights Act. Requires a policy or plan sponsor to notify the prescribing physician and the patient in writing 60 days before making a formulary change that alters the terms of coverage or discontinues coverage for a prescribed drug that the patient is receiving. Contains provisions for receiving the notice electronically. Provides that a policy or plan sponsor may provide the patient with the written notification, along with a 60-day supply of the prescription drug, at the time the patient requests a refill. Provides that nothing in the provisions prohibits insurers or pharmacy benefit managers from using certain managed pharmacy care tools so long as an exception process is in place allowing the prescriber to petition for coverage a non-preferred drug if sufficient clinical reasons justify an exception to the normal protocol.

Actions 

Date	Chamber	Action
2/16/2018	Senate	Filed with Secretary by Sen. Elgie R. Sims, Jr.
2/16/2018	Senate	First Reading
2/16/2018	Senate	Referred to Assignments
2/27/2018	Senate	Assigned to Insurance
4/13/2018	Senate	Rule 2-10 Committee Deadline Established As April 27, 2018
4/27/2018	Senate	Rule 3-9(a) / Re-referred to Assignments
1/9/2019	Senate	Session Sine Die

Back To Top